--- title: "08:52 ETKuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm" type: "News" locale: "en" url: "https://longbridge.com/en/news/293935876.md" description: "Kuehn Law, PLLC is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) for potential breaches of fiduciary duty and self-dealing by officers and directors. Long-term shareholders may be entitled to damages and governance reforms. The firm invites affected investors to contact Sophia Anne Silayan for a free consultation, noting that time limits may apply to enforce rights." datetime: "2026-07-27T12:53:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293935876.md) - [en](https://longbridge.com/en/news/293935876.md) - [zh-HK](https://longbridge.com/zh-HK/news/293935876.md) generator: "portal-rs" --- # 08:52 ETKuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm , /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of **Summit Therapeutics Inc. (NASDAQ: SMMT)** breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are **a long-term** **SMMT stockholder** please contact Sophia Anne Silayan by email at \[email protected\] or call (833) 672-0814. **The consultation and case are free with no obligation to you.** **Kuehn Law pays all case costs and does not charge its investor clients.** *Shareholders should contact the firm immediately as there may be limited time to enforce your rights.* **Why Your Participation Matters:** As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. *Your investment. Your voice. Your future.*™ For additional information, please visit Shareholder Derivative Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts: Kuehn Law, PLL Justin Kuehn, Esq. 53 Hill Street, Suite 605 Southampton, NY 11968 \[email protected\] (833) 672-0814 SOURCE Kuehn Law, PLLC ### Related Stocks - [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md) ## Related News & Research - [Summit says FDA sets Nov. 14, 2026 action date for ivonescimab lung cancer filing](https://longbridge.com/en/news/296901535.md) - [Ivonescimab regimen shows OS superiority in Phase III HARMONi-GI1, Summit Therapeutics notes](https://longbridge.com/en/news/297053863.md) - [Credible Law Releases 2026 Merchant Cash Advance Litigation Report](https://longbridge.com/en/news/297194655.md) - [Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit | NAGE Stock News](https://longbridge.com/en/news/297046789.md) - [Summit Therapeutics Partner Highlights Positive Interim Data Milestone for Lead Cancer Therapy](https://longbridge.com/en/news/297076262.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**